60. 再生不良性貧血 Aplastic anemia Clinical trials / Disease details

臨床試験数 : 245 / 薬物数 : 318 - (DrugBank : 86) / 標的遺伝子数 : 44 - 標的パスウェイ数 : 166

5 trials found

diseases per page:

Showing 1 to 5 of 5 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05720234 (ClinicalTrials.gov)	November 10, 2022	11/1/2023	Avatrombopag Combined With IST as First-line Treatment for SAA	The Efficacy and Safety Study of AvatrombopagCombined With IST as First-line Treatment for Severe Ap ...	Severe Aplastic Anemia	Drug: avatrombopag	Institute of Hematology & Blood Diseases Hospital	NULL	Recruiting	12 Years	60 Years	All	53	Phase 2	China
2	NCT05571332 (ClinicalTrials.gov)	June 28, 2022	28/8/2022	Efficacy and Safety of AvatrombopagCombined With IST for the Treatment of HAAA and SAA With Abnormal ...	Efficacy and Safety of AvatrombopagCombined With IST for the Treatment of HAAA and SAA With Abnormal ...	Aplastic Anemia	Drug: Avatrombopag 20 MG Oral Tablet	Institute of Hematology & Blood Diseases Hospital	NULL	Recruiting	18 Years	70 Years	All	39	N/A	China
3	ChiCTR2200057674	2022-03-01	2022-03-15	Clinical study of Avatrombopagcombined with immunosuppressive therapy in the treatment of severe hep ...	A prospective clinical study of Avatrombopagcombined with immunosuppressive therapy in the treatment ...	Severe hepatitis-associated aplastic anaemia in children	Avatrombopag+IST: Avatrombopag;	Capital Medical University, National Center for Children’s Health	NULL	Pending	2	18	Both	Avatrombopag+IST:10;	Phase 4	china
4	ChiCTR2100050045	2021-09-01	2021-08-16	A Study to Assess the Safety and Efficacy of Avatrombopag in Chinese Patients with Aplastic Anemia	A Non-randomized, Open-label, Phase II Study to Assess the Safety and Efficacy of Avatrombopagin Chi ...	aplastic anemia	Group 1:Avatrombopag treatment;	Tianjin Medical University, General Hospitial	NULL	Pending	16	75	Both	Group 1:60;	Phase 4	China
5	NCT04728789 (ClinicalTrials.gov)	February 1, 2021	1/12/2020	Avatrombopag Usage in NSAA	Efficacy and Safety of Avatrombopagin Non-severe Aplastic Anemia - a Multicenter Prospective Single ...	Aplastic Anemia;Drug Effect	Drug: Avatrombopag 20 MG	Peking Union Medical College Hospital	NULL	Not yet recruiting	18 Years	75 Years	All	40	Phase 2/Phase 3	China

First Previous1Next Last